슈퍼너스 파마슈티컬스(Supernus Pharmaceuticals, Inc.)
US ˙ NasdaqGM ˙ US8684591089

SecuritySUPN / Supernus Pharmaceuticals, Inc.
InstitutionMan Group plc
Latest Disclosed Ownership74,992 shares
Latest Disclosed Value $ 3,876,336
Man Group plc reports 141.16% increase in ownership of SUPN / Supernus Pharmaceuticals, Inc.

On May 15, 2026 - Man Group plc filed a 13F-HR form disclosing ownership of 74,992 shares of Supernus Pharmaceuticals, Inc. (US:SUPN) valued at $3,876,336 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 31,097 shares of Supernus Pharmaceuticals, Inc.. This represents a change in shares of 141.16% during the quarter. The current value of the position is $3,352,142 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 74,992 43,895 141.16 3,876 150.87 0.0070
2026-02-17 2025-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 31,097 -63,984 -67.29 1,546 -65.99 0.0026
2025-11-14 2025-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 95,081 30,337 46.86 4,544 122.70 0.0079
2025-08-14 2025-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 64,744 24,123 59.39 2,041 53.38 0.0039
2025-05-15 2025-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 40,621 17,057 72.39 1,330 56.10 0.0034
2025-02-14 2024-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 23,564 -760 -3.12 852 12.40 0.0022
2024-11-14 2024-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 24,324 758 142.95 0.0020
2023-11-14 2023-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 312 -82.83 0.0010
2023-08-14 2023-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 60,462 1,817 26.80 0.0056
2023-05-15 2023-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,433 -1.44 0.0051
2023-02-14 2022-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 40,765 40,765 1,454 0.0052
2021-08-16 2021-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 0 -10,900 -100.00 0 -100.00
2021-05-17 2021-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 10,900 -191,628 -94.62 285 -94.41 0.0013
2021-02-16 2020-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 202,528 -50,800 -20.05 5,096 -3.47 0.0224
2020-11-16 2020-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 253,328 64,655 34.27 5,279 17.81 0.0208
2020-08-14 2020-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 188,673 62,582 49.63 4,481 97.57 0.0226
2020-05-15 2020-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 126,091 9,075 7.76 2,268 -18.27 0.0147
2020-02-18 2019-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 117,016 60,225 106.05 2,775 77.77 0.0091
2019-11-14 2019-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 56,791 16,411 40.64 1,561 16.84 0.0058
2019-08-14 2019-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 40,380 -97,077 -70.62 1,336 -72.26 0.0048
2019-05-15 2019-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 137,457 131,109 2,065.36 4,817 2,182.94 0.0183
2019-02-14 2018-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 6,348 -107,662 -94.43 211 -96.32 0.0009
2018-11-14 2018-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 114,010 -54,142 -32.20 5,740 -42.96 0.0210
2018-08-14 2018-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 168,152 -65,062 -27.90 10,063 -5.79 0.0414
2018-05-15 2018-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 233,214 233,214 10,681 0.0489
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.